(Philadelphia, PA) - Richard Aplenc, MD, MSCE, has been appointed an Assistant Professor in the Department of Pediatrics, division of Pediatric Oncology, at the University of Pennsylvania School of Medicine.

Dr. Aplenc earned his medical degree in 1994 from the University of Virginia. He earned his Masters of Science in Clinical Epidemiology at the University of Pennsylvania, and is currently pursuing a Doctoral Program in the same area there.

Dr. Aplenc's research interests include the molecular epidemiology of childhood cancers, with a focus on case control studies to evaluate the role of polymorphisms in drug metabolizing enzymes, and treatment outcome and toxicity in pediatric leukemia. He is currently working on several research projects studying genotypes and cancer. Dr. Aplenc is also collaborating with Dr. Jason Christie, also of the Center for Clinical Epidemiology and Biostatistics at the University of Pennsylvania, in a cohort study examining genetic modifiers of acute lung injury susceptibility and outcome. His research has been published in several journals including the Best Practice & Research Clinical Haematology, Accepted Genetics, Clinical Cancer Research, Cancer Research, and Leukemia.

Dr. Aplenc is a member of the American Association for Cancer Research, the American Society of Hematology and the American Society of Clinical Oncology. He is also an ad-hoc reviewer for the publications Cancer, Clinical Cancer Research and Medical and Pediatric Oncology.

# # #


Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $7.8 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 20 years, according to U.S. News & World Report’s survey of research-oriented medical schools. The School is consistently among the nation’s top recipients of funding from the National Institutes of Health, with $405 million awarded in the 2017 fiscal year.

The University of Pennsylvania Health System’s patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center — which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report — Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; Penn Wissahickon Hospice; and Pennsylvania Hospital – the nation’s first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine, and Princeton House Behavioral Health, a leading provider of highly skilled and compassionate behavioral healthcare.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2017, Penn Medicine provided $500 million to benefit our community.